c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
about
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisThe oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitorMACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer modelsMET receptor tyrosine kinaseDelphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation.A filter-based feature selection approach for identifying potential biomarkers for lung cancer.PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.Overexpression of MACC1 and the association with hepatocyte growth factor/c-Met in epithelial ovarian cancer.Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts.Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation.Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress.RanBPM regulates cell shape, arrangement, and capacity of the female germline stem cell niche in Drosophila melanogaster.C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypesAssociation of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.MET as a target for treatment of chest tumorsNovobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.Targeting the Met signaling pathway in renal cancer.Ethnic differences and functional analysis of MET mutations in lung cancer.Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical CancerMET pathway as a therapeutic target.Zinc protoporphyrin regulates cyclin D1 expression independent of heme oxygenase inhibition.Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma.The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer.Gene of the month: HGF.FOXC2 promotes colorectal cancer metastasis by directly targeting MET.Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer.PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.Imaging haematopoietic cells recruitment to an acute wound in vivo identifies a role for c-Met signalling.Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM.MACC1 expression levels as a novel prognostic marker for colorectal cancer.
P2860
Q24656948-E7EB6372-B632-422F-8107-2A898877686BQ28821187-4B40351A-ED11-4EF0-BA0B-FA62350D2705Q30157439-9A92F491-2713-433C-850C-677963D115F8Q33645135-B04AC2E5-06C5-4E6C-9734-D3331623FF24Q33756836-CD87BC0E-A277-4F17-9B84-FF8FC7315C58Q34340834-BCCEBA83-3BDF-4AE1-9C91-3D0ABEC34156Q35189076-63340A9F-7AAA-490D-B199-448A822B2D0AQ35562996-8B0C0FD5-B83F-4E93-9B09-F4BAC552870FQ35742089-374393B6-2D01-42C9-9342-4C057262674DQ35874388-CF331D0F-299D-459E-AB5C-2E3ECD2F13C4Q36085827-B0D15CDA-BEDE-4D42-AB07-2D5D4EBB6CCFQ36335655-4A8DA24B-A715-4AFE-A936-4A9138F23194Q36784932-CC962584-DA31-4C47-934D-BE152C8BDFBCQ36860347-C028E2A0-50B5-4383-935F-5EB6F55A03D4Q36967334-734442CB-2D49-4620-BFE9-AC0A8DF23EA0Q37141943-F7C567FF-4A3E-4F29-90C7-76922A696D21Q37232416-5EF5B66B-52D2-411A-B7C8-89A37DA42A12Q37320252-0A1049F4-CDD0-4767-8980-C3B993E99CBFQ37331862-1FE7C238-C6A3-4407-B4F3-AD524E1B9496Q37399540-687D0FB5-4E6E-4F38-B004-3FC2326AC71DQ37409629-5DC37FA2-D181-4154-B705-6A12DFAFD29DQ37427292-B568067B-78D9-4E02-9965-0DCD23E86426Q37479305-C5A9A1C1-B997-4C7E-A37F-CC9337BA512CQ37694792-08BD4337-9ABC-4974-95A0-F3278B8A1D73Q38239580-D86D898F-E7F7-4A7D-A5F1-EA1A1D3AC24CQ38380044-C1934F38-91DE-473B-BEA8-0C4BBC1CD8ECQ38445359-D37B51E8-22A3-4117-8D74-2E032548F328Q38757070-7D6E3050-AC35-4A96-BA26-19941B03B11AQ38806819-CB9643C7-F6FB-4F69-97C4-2D61999BA088Q38941681-3986E49B-8A3D-4EE6-9132-5989EAAE19BBQ38986019-C22B1A8F-6029-419E-9463-46AF02D0913FQ38986202-809E678F-E708-40E2-BC6D-76ABDA8B1853Q39096429-21D95798-8744-4599-938A-B8F011FCB87BQ39463034-1B53F282-4AC8-4B0A-B63E-76415AA574B2Q39753803-513D5B47-8B64-470F-827B-B25766C8BE22Q39896091-AFBCB395-0ADA-4DAE-91FC-0BC9EA20A19AQ40104775-90149336-B0D5-4310-838C-7E9DDB873013Q42373819-E17C29D9-FDA3-4DC7-AAD7-0426E08585CAQ42693009-177BAC37-EA27-4316-BA4D-58244F155CDBQ42931083-F3D5693D-7F2C-476F-84AC-446CF4EBD020
P2860
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@ast
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@en
type
label
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@ast
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@en
prefLabel
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@ast
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@en
P2860
P1476
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.
@en
P2093
Martin Sattler
P2860
P2888
P304
P356
10.1007/S11912-007-0005-4
P50
P577
2007-03-01T00:00:00Z